[ANIP]
Mid
Mid
2026-10-13 00:42:18
ANI Pharma reports positive phase 4 data for Iluvien in non-infectious uveitis
Mid
2026-08-08 03:51:47
ANI projects $1.08B-$1.14B 2026 revenue as it revises Cortrophin to $520M-$540M amid gout sales force expansion
Mid
2026-08-07 19:59:12
ANI Pharmaceuticals Non-GAAP EPS of $2.21 beats by $0.17, revenue of $266.04M beats by $5.91M
Row
2026-08-06 22:27:30
ANI Pharmaceuticals Q2 2026 Earnings Preview
Row
2026-07-07 10:55:22
Form 4 ANI Pharmaceuticals Inc For: 6 July